Nausea News and Research

RSS

Nausea is the sensation of unease and discomfort in the upper stomach and head with an urge to vomit. An attack of nausea is known as a qualm.

Researchers explore the link between immunoglobulins and blood profile in severe SARS-CoV-2 patients

A new study illustrated the association of immunoglobulins with blood characteristics in COVID-19 patients.

6 Apr 2022

Sodium thiosulfate shows no benefits for reducing heart damage following a heart attack

Sodium thiosulfate showed no benefits for reducing injury to damaged areas of heart muscle following a heart attack, in a study presented at the American College of Cardiology's 71st Annual Scientific Session.

5 Apr 2022

Improving our understanding of a severe pregnancy sickness (Hyperemesis Gravidarum)

News-Medical talks to Dr. Marlena Fejzo about a breakthrough in the understanding of hyperemesis gravidarum, and how it could improve maternal health around the world.

5 Apr 2022

Athletes' post-concussion problems originate in an injury to the vestibular nerve

Depression, dizziness, difficulty focusing the gaze and balance problems. Many professional athletes who have sustained head trauma in sports have lingering symptoms that affect everyday life. Little help has been available as the cause has been unknown.

4 Apr 2022

What are the long-term symptoms of SARS-CoV-2 infection?

Researchers determines whether some symptoms of long-COVID are more specifically associated with SARS-CoV-2 infection than other conditions.

4 Apr 2022

Patiromer lowers hyperkalemia risk in heart failure patients taking RAASi therapy

Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had significantly lower blood potassium levels when taking patiromer—a drug that helps to prevent the body from absorbing too much potassium—compared with a placebo, in a study presented at the American College of Cardiology's 71st Annual Scientific Session.

3 Apr 2022

Tablet containing cannabidiol effectively reduces pain after shoulder surgery

An orally absorbed tablet containing cannabidiol (CBD) effectively reduces pain after shoulder surgery with no safety concerns, a new study finds.

25 Mar 2022

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

A new study has focussed on screening and identification of possible SMIs of this PPI for COVID-19.

25 Mar 2022

Antidopaminergic antiemetics associated with elevated risk of ischemic stroke

Drugs known as antidopaminergic antiemetics (ADAs) that are widely used to relieve nausea and vomiting caused, for instance, by migraine, chemotherapy or radiotherapy, and after surgery are associated with an increased risk of ischaemic stroke, finds a study published by The BMJ today.

24 Mar 2022

T-cell and neutralizing antibody response after a third COVID-19 vaccine dose in hemodialysis patients

Researchers compare the impact of a third mRNA COVID-19 vaccine in hemodialysis patients by measuring antibody levels and IFN-γ responses.

23 Mar 2022

Study finds lesser number of female principal investigators in cardiovascular clinical trials

Despite recent efforts to improve women's leadership in cardiovascular clinical trial research over the last decade, the number of female principal investigators (PIs) still falls well below the number of males leading similar heart studies, according to a study presented at the American College of Cardiology's 71st Annual Scientific Session.

23 Mar 2022

Women receive fewer life-saving heart procedures than men

In the first study to examine differences by sex and race in outcomes following the seven most common procedures for heart problems, researchers found that women are less likely to undergo these procedures- and even when women do receive these procedures, they are more likely than men to die while in the hospital, according to data that will be presented at the American College of Cardiology's 71st Annual Scientific Session.

23 Mar 2022

A psychedelic drug plus psychotherapy could help improve PTSD symptoms

Post-traumatic stress disorder (PTSD) affects millions of people each year, mostly survivors and witnesses of terrifying or shocking events, such as warfare, assaults or disasters. Because existing treatments don't work for everyone, new therapies are urgently needed.

22 Mar 2022

Nausea News and Research

Further Reading

Researchers explore the link between immunoglobulins and blood profile in severe SARS-CoV-2 patients

Sodium thiosulfate shows no benefits for reducing heart damage following a heart attack

Improving our understanding of a severe pregnancy sickness (Hyperemesis Gravidarum)

Athletes' post-concussion problems originate in an injury to the vestibular nerve

What are the long-term symptoms of SARS-CoV-2 infection?

Patiromer lowers hyperkalemia risk in heart failure patients taking RAASi therapy

Tablet containing cannabidiol effectively reduces pain after shoulder surgery

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

Antidopaminergic antiemetics associated with elevated risk of ischemic stroke

T-cell and neutralizing antibody response after a third COVID-19 vaccine dose in hemodialysis patients

Study finds lesser number of female principal investigators in cardiovascular clinical trials

Women receive fewer life-saving heart procedures than men

A psychedelic drug plus psychotherapy could help improve PTSD symptoms

Women less likely to receive lifesaving intervention for cardiogenic shock than men

Rising global temperatures likely to increase the health burden from hyponatremia

Effect of COVID-19 mRNA vaccine on in vitro glial cells of the brain studied by Raman spectroscopy and imaging

Breakthrough SARS-CoV-2 infection peaks at 5 months

Study suggests history of childhood traumas may increase the risk of long COVID

mRNA vaccines found to be highly effective against COVID-19 infections before the emergence of SARS-CoV-2 Delta variant

Antibody levels against SARS-CoV-2 spike protein up to 12 months after COVID-19 infection in non-vaccinated individuals

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News